Courses

Available courses include:

The Basic Science and the Biological Basis for Sex- and Gender-Related Differences

This course is designed to give the student a basic scientific understanding of the major physiological differences between the sexes, the influences these differences have on illness and health outcomes, and the implications for policy, medical research, and health care.

The course includes six lessons, each of which will take from 20 minutes to an hour to complete. Taking the course is free and continuing education credit can be awarded for successful completion of the course. To receive credit, students will be required to complete all six lesson quizzes with a score of at least 70 percent and to complete a brief course evaluation form. Partial credit will not be awarded to students who complete only selected lessons. Please see the continuing education page for more information.

This course was first launched on June 1, 2006. Course content will be revised periodically; however revision dates will be noted.

To take the course for credit or non-credit, please set up your account by completing the registration form, or if you have already created an account, please login.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality and scientific integrity of this CME activity.

Course Learning Objectives
Accreditation and Credit Designation Statement
Policy on Speaker and Provider Disclosure
Course Writers
Course Planning Committee

Course Learning Objectives

Following the course, the participant will be able to:

Contrast and compare key regulatory U.S. Department of Health and Human Services policies significant to inclusion of women in clinical research and human subject protection.
Evaluate the appropriateness of the design and analysis of preclinical and clinical research studies to detect and quantify potential sex and gender differences.
Describe the scientific basis of known sex and gender differences.
Identify known sex and gender differences with regard to diseases, and differences in response to or effects of drugs and other medical interventions in the treatment and management of these conditions.

Accreditation Statement and Credit Designation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine, The National Institutes of Health, and The U.S. Food and Drug Administration. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 6 AMA PRA Category 1 Credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Speaker and Provider Disclosure

It is the policy of The Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.

Course Writers

Name	Degree	Title	Organization
Eleanor Hanna (NIH Activity Director)	Ph.D.	Associate Director for Special Projects and Centers	NIH, Office of Research on Women’s Health
Angela Bates	M.B.A.	Program Analyst	NIH, Office of Research on Women’s Health
Susan Wood	Ph.D.	Former Director	FDA, Office of Women’s Health
Deborah Kallgren	B.S.	Health Programs Coordinator	FDA, Office of Women’s Health
Pamela Scott	Ph.D.	Health Programs Coordinator	FDA, Office of Women’s Health
Carmen Sapienza	Ph.D.	Professor of Pathology and Laboratory Medicine; Associate Director of the Fels Institute for Cancer Research and Molecular Biology	Temple University School of Medicine
Joseph Kaczmarczyk	D.O., M.P.H.	Medical Officer	FDA, Office of Women’s Health
Myong-Jin Kim	Pharm.D.	Senior Clinical Pharmacologist	FDA, Division of Clinical Pharmacology 3
Gurvaneet Randhawa	M.D., M.P.H.	Senior Fellow	Center for Outcomes and Evidence, Agency for Healthcare Research and Quality

Course Planning Committee

Name	Degree	Title	Organization
Vivian Pinn	M.D.	Associate Director for Research on Women's Health, Director	NIH, Office of Research on Women’s Health
Eleanor Hanna (NIH Activity Director)	Ph.D.	Associate Director for Special Projects and Centers	NIH, Office of Research on Women’s Health
Angela Bates	M.B.A.	Program Analyst	NIH, Office of Research on Women’s Health
Florence Haseltine	Ph.D., M.D.	Director	NIH, Center for Population Research
Patrice Desvigne-Nickens	M.D.	Leader, Cardiovascular Medicine Scientific Review Group	NIH, National Heart, Lung, and Blood Institute
Susan Wood	Ph.D.	Former Director	FDA, Office of Women’s Health
Deborah Kallgren	B.S.	Health Programs Coordinator	FDA, Office of Women’s Health
Pamela Scott	Ph.D.	Health Programs Coordinator	FDA, Office of Women’s Health
Joseph Kaczmarczyk	D.O, M.P.H.	Medical Officer	FDA, Office of Women’s Health
Myong-Jin Kim	Pharm.D.	Senior Clinical Pharmacologist	FDA, Division of Clinical Pharmacology 3